232 related articles for article (PubMed ID: 34103538)
1. Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
Goodwin PJ; Dowling RJO; Ennis M; Chen BE; Parulekar WR; Shepherd LE; Burnell MJ; Vander Meer R; Molckovsky A; Gurjal A; Gelmon KA; Ligibel JA; Hershman DL; Mayer IA; Whelan TJ; Hobday TJ; Rastogi P; Rabaglio-Poretti M; Lemieux J; Thompson AM; Rea DW; Stambolic V
NPJ Breast Cancer; 2021 Jun; 7(1):74. PubMed ID: 34103538
[TBL] [Abstract][Full Text] [Related]
2. Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
Goodwin PJ; Dowling RJO; Ennis M; Chen BE; Parulekar WR; Shepherd LE; Gelmon KA; Whelan TJ; Ligibel JA; Hershman DL; Mayer IA; Hobday TJ; Rastogi P; Rabaglio-Poretti M; Lemieux J; Thompson AM; Rea DW; Stambolic V
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34485814
[TBL] [Abstract][Full Text] [Related]
3. Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
Goodwin PJ; Parulekar WR; Gelmon KA; Shepherd LE; Ligibel JA; Hershman DL; Rastogi P; Mayer IA; Hobday TJ; Lemieux J; Thompson AM; Pritchard KI; Whelan TJ; Mukherjee SD; Chalchal HI; Oja CD; Tonkin KS; Bernstein V; Chen BE; Stambolic V
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25740979
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
Pimentel I; Chen BE; Lohmann AE; Ennis M; Ligibel J; Shepherd L; Hershman DL; Whelan T; Stambolic V; Mayer I; Hobday T; Lemieux J; Thompson A; Rastogi P; Gelmon K; Rea D; Rabaglio M; Ellard S; Mates M; Bedard P; Pitre L; Vandenberg T; Dowling RJO; Parulekar W; Goodwin PJ
J Natl Cancer Inst; 2021 Feb; 113(2):192-198. PubMed ID: 33527137
[TBL] [Abstract][Full Text] [Related]
5. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
6. The
Cuyàs E; Buxó M; Ferri Iglesias MJ; Verdura S; Pernas S; Dorca J; Álvarez I; Martínez S; Pérez-Garcia JM; Batista-López N; Rodríguez-Sánchez CA; Amillano K; Domínguez S; Luque M; Morilla I; Stradella A; Viñas G; Cortés J; Joven J; Brunet J; López-Bonet E; Garcia M; Saidani S; Queralt Moles X; Martin-Castillo B; Menendez JA
Front Oncol; 2019; 9():193. PubMed ID: 30984619
[No Abstract] [Full Text] [Related]
7. Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32.
Lohmann AE; Liebman MF; Brien W; Parulekar WR; Gelmon KA; Shepherd LE; Ligibel JA; Hershman DL; Rastogi P; Mayer IA; Hobday TJ; Lemieux J; Thompson AM; Pritchard KI; Whelan TJ; Mukherjee SD; Chalchal HI; Bernstein V; Stambolic V; Chen BE; Goodwin PJ;
Breast Cancer Res Treat; 2017 Jul; 164(2):371-378. PubMed ID: 28447237
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study.
Bassols J; Martínez-Calcerrada JM; Osiniri I; Díaz-Roldán F; Xargay-Torrent S; Mas-Parés B; Dorado-Ceballos E; Prats-Puig A; Carreras-Badosa G; de Zegher F; Ibáñez L; López-Bermejo A
PLoS One; 2019; 14(12):e0226303. PubMed ID: 31821361
[TBL] [Abstract][Full Text] [Related]
9. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
11. The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial.
Davis SR; Robinson PJ; Jane F; White S; Brown KA; Piessens S; Edwards A; McNeilage J; Woinarski J; Chipman M; Bell RJ
Clin Endocrinol (Oxf); 2018 Nov; 89(5):605-612. PubMed ID: 30107043
[TBL] [Abstract][Full Text] [Related]
12. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
13. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
[TBL] [Abstract][Full Text] [Related]
14. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
[TBL] [Abstract][Full Text] [Related]
16. Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).
Hershman DL; Chen BE; Sathe C; Parulekar WR; Lemieux J; Ligibel JA; Gelmon KA; Whelan TJ; Goodwin PJ
Breast Cancer Res Treat; 2023 Jul; 200(1):93-102. PubMed ID: 37157006
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
18. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.
Baptista T; Rangel N; Fernández V; Carrizo E; El Fakih Y; Uzcátegui E; Galeazzi T; Gutiérrez MA; Servigna M; Dávila A; Uzcátegui M; Serrano A; Connell L; Beaulieu S; de Baptista EA
Schizophr Res; 2007 Jul; 93(1-3):99-108. PubMed ID: 17490862
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
Nwosu BU; Maranda L; Cullen K; Greenman L; Fleshman J; McShea N; Barton BA; Lee MM
PLoS One; 2015; 10(9):e0137525. PubMed ID: 26367281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
